Table 4.
In vivo efficacy of treatment with CKOMe
Treatment/compounda | Result of treatment at end of study (%) |
||
---|---|---|---|
Clinical cure | Failure | Clinical improvement | |
CKOMe without light | 67 | 0 | 33 |
CKOMe + 2 h of light | 67 | 33 | 0 |
CKOMe + 4 h of light | 83 | 17 | 0 |
Meglumine antimoniate, curative dose | 67 | 33 | 0 |
Meglumine antimoniate, subcurative dose | 67 | 33 | 0 |
n = 6 animals per group.